Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 1998
Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation
C Hesdorffer, J Ayello, M Ward, et al.
Neurosurgery
|
April 14, 1999
Supratentorial ependymomas in adult patients
T H Schwartz, S Kim, R S Glick, et al.
Neuro-Oncology
|
July 24, 2001
Long-term quality of life and neuropsychologic functioning for patients with CNS germ-cell tumors: from the First International CNS Germ-Cell Tumor Study
S A Sands, S J Kellie, A L Davidow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1996
Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study
C Balmaceda, G Heller, M Rosenblum, et al.
Brain : a Journal of Neurology
|
March 2, 1999
Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders
J Dalmau, S H Gultekin, R Voltz, et al.
Bone Marrow Transplantation
|
August 22, 2002
Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer
L T Vahdat, C Balmaceda, K Papadopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 1998
Phase I trial of sequential high-dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer
L T Vahdat, K Papadopoulos, C Balmaceda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
Reduction of paclitaxel-induced peripheral neuropathy with glutamine
L Vahdat, K Papadopoulos, D Lange, et al.
Journal of Neuro-Oncology
|
January 5, 2000
A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors
K P Papadopoulos, C Balmaceda, M Fetell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer
C A Hudis, A D Seidman, J P Crown, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 1998
Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation
C Hesdorffer, J Ayello, M Ward, et al.
Neurosurgery
|
April 14, 1999
Supratentorial ependymomas in adult patients
T H Schwartz, S Kim, R S Glick, et al.
Neuro-Oncology
|
July 24, 2001
Long-term quality of life and neuropsychologic functioning for patients with CNS germ-cell tumors: from the First International CNS Germ-Cell Tumor Study
S A Sands, S J Kellie, A L Davidow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1996
Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study
C Balmaceda, G Heller, M Rosenblum, et al.
Brain : a Journal of Neurology
|
March 2, 1999
Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders
J Dalmau, S H Gultekin, R Voltz, et al.
Bone Marrow Transplantation
|
August 22, 2002
Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer
L T Vahdat, C Balmaceda, K Papadopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 1998
Phase I trial of sequential high-dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer
L T Vahdat, K Papadopoulos, C Balmaceda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
Reduction of paclitaxel-induced peripheral neuropathy with glutamine
L Vahdat, K Papadopoulos, D Lange, et al.
Journal of Neuro-Oncology
|
January 5, 2000
A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors
K P Papadopoulos, C Balmaceda, M Fetell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer
C A Hudis, A D Seidman, J P Crown, et al.
Page
of 4